Kevin T. Conroy - Mar 7, 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role: President and CEO, Director
Signature: /s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Stock symbol: EXAS
Transactions as of: Mar 7, 2025
Transactions value $: -$809,338
Form type: 4
Date filed: 3/10/2025, 05:00 PM
Previous filing: Mar 4, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXAS	Common Stock	Options Exercise	$1.49M	+66.7K	+5.87%	$22.38	1.2M	Mar 7, 2025	Direct	F1
transaction	EXAS	Common Stock	Tax liability	-$2.3M	-48.9K	-4.07%	$47.06	1.15M	Mar 7, 2025	Direct	F1, F2
holding	EXAS	Common Stock						28.6K	Mar 7, 2025	Held in 401(k) Plan
holding	EXAS	Common Stock						73.3K	Mar 7, 2025	Held in Grantor Retained Annuity Trust
holding	EXAS	Common Stock						72.1K	Mar 7, 2025	Held in Grantor Retained Annuity Trust
holding	EXAS	Common Stock						21.7K	Mar 7, 2025	Held in Grantor Retained Annuity Trust
holding	EXAS	Common Stock						21.7K	Mar 7, 2025	Held in Grantor Retained Annuity Trust
holding	EXAS	Common Stock						21.7K	Mar 7, 2025	Held in Grantor Retained Annuity Trust
holding	EXAS	Common Stock						102K	Mar 7, 2025	Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EXAS	Stock Options (Right to Buy)	Options Exercise	$0	-66.7K	-100%	$0.00	0	Mar 7, 2025	Common Stock	66.7K	$22.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Conroy was awarded 71,000 stock options on March 9, 2015. 66,723 of these stock options were not exercised during the 10-year term of the award. Under the terms of the options, they were automatically exercised on the business day preceding the expiration date of the options, and 48,929 shares were withheld from Mr. Conroy to pay the exercise price and taxes due upon exercise of the options. As a result, Mr. Conroy increased his holdings of Exact Sciences shares by 17,794 shares or approximately 1.6%.
F2	In addition to the shares of Common Stock reported on this Form 4, which total 1,494,973 shares, Mr. Conroy also holds, in the aggregate, an additional 663,578 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

Content

Mr. Conroy was awarded 71,000 stock options on March 9, 2015. 66,723 of these stock options were not exercised during the 10-year term of the award. Under the terms of the options, they were automatically exercised on the business day preceding the expiration date of the options, and 48,929 shares were withheld from Mr. Conroy to pay the exercise price and taxes due upon exercise of the options. As a result, Mr. Conroy increased his holdings of Exact Sciences shares by 17,794 shares or approximately 1.6%.

In addition to the shares of Common Stock reported on this Form 4, which total 1,494,973 shares, Mr. Conroy also holds, in the aggregate, an additional 663,578 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.